NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ascribe Bio

Ascribe Bio

Private
Ithaca, New YorkHealthcare & Life Scienceshttps://ascribebio.com/

Last Round

Series A

Oct 14, 2025

Total Funding Raised

$12.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ascribe Bio is an agricultural technology company that develops natural crop protection solutions derived from small molecules found in the soil microbiome.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biofungicidecrop protectionbiologicalsagtechsoil microbiomesustainable agriculturebiopesticideseed treatmentfoliar sprayagricultural biotechnologyascarosidescrop resiliencegreen chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ascribe Bio Comparables

Compare Ascribe Bio with similar companies based on industry and business-model similarity.

Ascribe Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Innatrix, Inc.
81%
Micropep
81%
Terramera
78%

Ascribe Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 14, 2025
Corporate FundingJan 29, 2025
GrantNov 17, 2021

Ascribe Bio Investors

Notable investors and investment history

Ascribe Bio investors
InvestorRounds
Cultivation CapitalSeries A
ICIG VenturesCorporate Funding
Ponderosa VenturesGrant
Acre Venture PartnersSeries A, Grant
Syngenta Group VenturesSeries A
Trailhead CapitalSeries A, Grant
Grow NYGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 14, 2025

    $12M round completed.

Ascribe Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ascribe Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ascribe Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersIthaca, New York
Employee Range14
Year Founded2017
Last FundingOct 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.